Clinical Nutrition Products - Global Strategic Business Report 2015: Improving Healthcare Expenditure to Drive Demand

DUBLIN, Mar. 11, 2015 /PRNewswire/ --Research and Markets

 (http://www.researchandmarkets.com/research/d96jd4/clinical) has announced the addition of the "Clinical Nutrition Products - Global Strategic Business Report" report to their offering.

This report analyzes the worldwide markets for Clinical Nutrition Products in US$ Million by the following Product Segments: Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa, and Latin America.

Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

The report profiles 64 companies including many key and niche players such as:

- Abbott Nutrition
- American HomePatient, Inc.
- Baxter International, Inc.
- B. Braun Melsungen AG
- Claris Lifesciences Ltd.

Key Topics Covered:

1. INDUSTRY OVERVIEW

• A Bird's Eye View of the Clinical Nutrition Products Market
• Emerging Markets: The New Hotspots for Growth
• Infant Nutrition: Rapid Growth in Store
• Infant Formula Market: Emerging Markets to Drive Growth
• Competitive Landscape
• Enteral Nutrition Market
• Major Players in the Enteral Nutrition and Enteral Infant Nutrition Market
• Parenteral Nutrition Market
• Leading Players Operating in the Market for Parenteral Nutrition
• Select Parenteral Nutrition Products by Company

2. MARKET DRIVERS, TRENDS & ISSUES

• Impact of Recession in Retrospect and the Road Ahead
• Improving Healthcare Expenditure to Drive Demand
• Aging Population: A Strong Growth Driver
• Rising Incidence of Chronic Diseases to Kindle Market Growth
• World Cancer Statistics: Incidence and Mortality Data
• Cancer Prone Sites based on Age
• Diabetes Mellitus: Another Major Chronic Condition
• Clinical Nutrition in Treatment of Malnutrition: Significant Growth Opportunities
• Non-volitional Nutritional Support Therapy
• Vital for Combating Malnutrition during Hospitalization
• Shift towards Home Care Boosts Demand for Clinical Nutrition Products
• Changing Health and Social Care Factors Favor Home Enteral Feeding
• Rising Number of Premature Births Drives Infant Clinical Nutrition Products Market
• Preterm Birth Statistics from WHO
• Demand for Personalized Medicine to Bode Well for Clinical Nutrition Products Market
• Product Innovations Blur the Lines between Medicine and Foods
• Surging Demand for Omega-3 Fatty Acids-Fortified Clinical Nutrition Products
• Advances in Enteral Feeding Devices: Positive Outlook for Enteral Nutrition Market
• Rising Incidence of Pediatric Crohn's Disease Fuels Enteral Nutrition Market
• Specialized Formula Products Inundate the Market
• Soy-based Infant Formula Gains Popularity
• Pre-mixed IV Solutions: A Step towards Safer Medication Practices
• Growing Demand for Low-Cost Parenteral Nutrition Solutions
• Rising Preference for Multi-Chamber Bags to Lower Cost of Parenteral Nutrition Therapy
• Increasing Popularity of Intravenous Vitamin C for Cancer Treatment
• Infection Control: A Prime Concern in Parenteral Nutrition
• Complacency of Hospitals & Worker/Patient Safety: A Key Issue
• Favorable Clinical Findings Strengthens Prospects for Enteral Nutrition
• Rising Preference for Enteral Nutrition
• A Threat to Parenteral Nutrition Market
• Advantages and Disadvantages of Enteral Nutrition over Parenteral Nutrition
• Major Challenges Confronting Medical Nutrition Products' Marketers
• Barriers to Widespread Adoption of Clinical Nutrition Products
• Reasons for Not Prescribing Clinical Nutrition Products

3. PRODUCT OVERVIEW

• Clinical Nutrition: An Introduction
• Diseases Indicating Administering of Clinical Nutrition
• Advantages of Clinical Nutrition
• Classification of Clinical Nutrition Products
• Infant Nutrition Products
• List of Infant Nutrition Products
• Types of Infant Nutrition Products
• Specialized Milk-Based Formulas
• Soy-based Infant Formula
• Amino Acid-based Formulas
• Probiotic Infant Formulas
• Prebiotics in Infant Nutrition
• Exempt Infant Formulas
• Human Milk Oligosaccharides
• Nutrition Products for Preterm Infants
• Premature Infant Formula
• Transitional Formulas
• Human Milk Fortifiers
• Metabolic Infant Formulas
• Follow-up or Follow-on Formulas
• Enteral Administration of Infant Formulas in Neonatal Intensive Care and General Healthcare Settings
• Nipple Feeding
• Tube Feeding
• Enteral Nutrition Products
• Enteral Nutrition by Age
• Enteral Nutrition for Patients aged 21 and older
• Enteral Nutrition for Patients below 21 Years
• Various Types of Enteral Feeding or Tube Feeding
• What Constitutes Enteral Nutrition Diets?
• Home-Made Diets
• Commercial Enteral Formulas
• Elemental Formulas
• Oligomeric Formulas
• Polymeric Formulas
• Special Formulas
• Pulmonary Formulas
• Liver Formulas
• Renal Formulas
• Diabetes Formulas
• Gastrointestinal Dysfunction Formulas
• Immuno-modulatory Formulas
• Enteral Nutrition in Patients with Acute Renal Failure (ARF)
• Enteral Nutrition in Conservatively Treated Patients with Chronic Renal Failure (CRF)
• Enteral Nutrition in Haemodialysis Patients
• Enteral Nutrition in Chronic Ambulatory Peritoneal Dialysis (CAPD) Patients
• Complications of Enteral Feeding
• Complications Associated with Enteral Tube Feeding
• Parenteral Nutrition
• Sources of Parenteral Solutions
• Routes of Administration
• Types of Parenteral Nutrition Solutions
• Total Parenteral Nutrition (TPN)
• TPN Formulation
• Partial Parenteral Nutrition (PPN)
• Home Parenteral Nutrition
• Parenteral Nutrition Formulations
• Standard Solutions
• Three-in-One Standard Bags
• Two-in-one Standard Bags
• Individual Solutions
• Non-Standard Solutions
• Classification of Parenteral Nutrition by Type of Nutrients
• Amino Acids
• Carbohydrates
• Lipids
• Minerals & Electrolytes
• Micronutrients
• Vitamins
• Trace Elements
• Large and Small Volume Parenteral Solutions
• Large Volume Parenteral (LVP) Solutions
• Small Volume Parenteral (SVP) Solutions
• IV Fat Emulsions
• Enabling Maintenance of Bodyweight

4. PRODUCT INNOVATIONS/INTRODUCTIONS/ APPROVALS

• Otsuka Introduces HINE E-GEL Concentrated Liquid Nutrition Product
• Alaska Introduces Friso 4 Infant Formula
• Fresenius Kabi Obtains FDA Approval for Perikabiven® and Kabiven®
• B. Braun Obtains FDA Approval for Nutrilipid® 20% for Parenteral Nutrition
• Ingredion Europe Introduces UNI-PURE IMF 2332 and UNI-PURE IMF 8561 Infant Nutrition Product
• Fonterra China to Launch Self-Branded Infant Formula in China
• FDA Clears Fresenius Kabi for Emergency Import of Injectionable TPN Drugs
• Marck Biosciences Receives MCC Approval for Six Pharma Products
• Restore Health Pharmacy Launches High Quality Nutritional Supplement
• Inergetics Introduces Surgex Ready to Drink Nutritional Beverage
• Arla Foods Ingredients Introduces Revolutionary Whey Protein
• Nestlé Health Science Rolls Out SpikeRight® PLUS for Enteral Safety
• Claris Receives USFDA Approval for Marketing Products in the US

5. RECENT INDUSTRY ACTIVITY

• Nestlé Sets Up Health Science Manufacturing Plant
• Fonterra to Buy Stake in Beingmate
• Fonterra Collaborates with Beingmate to Meet Infant Formula Demand
• Baxter Recalls Select Lots of Parenteral Nutrition Products
• ITH Pharma Recalls Lipid Phase Parenteral Nutrition Products
• Unibrands and ICI to Market and Distribute Morinaga's Infant Formula in Pakistan
• Abbott Receives Approval for ENEVO Liquid for Enteral Use
• Nestlé to Construct Infant Formula Plant in Mexico
• Abbott Inaugurates Nutrition Production Facility in Haiti
• Baxter Recalls Select Lots of Premix Parenteral Nutrition Products
• Baxter Collaborates with JW Holdings for Omega 3 Lipids
• Mead Johnson Establishes New Manufacturing and Research & Development Complex
• Nestle Health Science Purchases Pamlab
• Aspen Acquires IP Rights in Infant Nutritional Businesses of Nestlé
• Danone Completes Acquisition of Wockhardt's Nutrition Business
• Abbott Nutrition Discontinues Enteral Device Business in the US and Puerto Rico
• Danone Recalls Infant Formula Products in Asia
• Yasheng Group Enters Joint Venture with IBC International LLC
• Humana Establishes Offices in UAE
• FDA Approves Clinolipid Lipid Injectable Emulsion
• Nestle Acquires Pfizer Nutrition
• Aperture Health Takes Over Triad Therapeutics
• B Braun Acquires Nutrichem
• Mead Johnson Nutrition Enters into Joint Venture with Sancor
• Abbott Plans Collaboration with Syngene for Nutrition R&D Unit
• AarhusKarlshamn Expands Capacity to Produce InFat
• Abbott to Construct Nutrition Production Facility in Ohio
• BioGaia Enters into a Collaboration Agreement with Nestlé
• Claris Lifesciences Enters into JV with Otsuka Pharma and Mitsui for Indian Market

6. FOCUS ON SELECT GLOBAL PLAYERS

• Abbott Nutrition (US)
• American HomePatient, Inc. (US)
• Baxter International, Inc. (US)
• B. Braun Melsungen AG (Germany)
• Claris Lifesciences Ltd. (India)
• Groupe Danone (France)
• Nutricia North America (US)
• Fresenius Kabi AG (Germany)
• Hospira, Inc. (US)
• Mead Johnson Nutrition Company (US)
• Meiji Co., Ltd. (Japan)
• Nestlé Health Science S.A (Switzerland)
• Otsuka Pharmaceutical Factory, Inc. (Japan)
• Sino-Swed Pharmaceutical Corp, Ltd. (China)

7. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 64 (including Divisions/Subsidiaries 88)

• The United States (27)
• Canada (1)
• Japan (7)
• Europe (27)
• France (5)
• Germany (4)
• The United Kingdom (4)
• Italy (1)
• Spain (1)
• Rest of Europe (12)
• Asia-Pacific (Excluding Japan) (23)
• Latin America (3)

For more information visit http://www.researchandmarkets.com/research/d96jd4/clinical

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

Related Links

http://www.researchandmarkets.com